Managing thrombotic risk in pregnancy: A free webinar for World Thrombosis Day
Pregnancy changes how the body manages clotting risk, and understanding that shift starts in the lab. A free webinar, supported by Sysmex, examines thrombotic risk in pregnancy from three angles: diagnosis, treatment and research.
Researchers and clinicians will discuss how thrombotic risk is assessed and managed before, during and after pregnancy, and what current evidence means for patient care.
Preregister by Oct. 6 for early access to this World Thrombosis Day webinar. The live premiere is Oct. 12.
Why this webinar matters
Thrombotic risk in pregnancy does not stay constant. It shifts before conception, changes throughout pregnancy and remains elevated for weeks after delivery. Managing that risk takes more than clinical judgment. It takes strong laboratory support, and that is what this webinar examines.
Who should attend
This webinar is designed for thrombosis professionals, OB-GYNs, lab technicians and researchers who want a practical, lab-informed view of thrombotic risk management in pregnancy. Whether you diagnose, treat or study thrombotic risk, this session offers perspective you can apply directly to patient care and research.
Don’t wait to save your spot. Register today.
What you will learn
In this 45-minute session, three experts examine how laboratory support guides care across the reproductive journey, from conception through pregnancy and beyond:
- How thrombotic risk shifts before conception, throughout pregnancy and postpartum
- How lab testing supports early diagnosis of thrombotic risk
- How lab results shape treatment and anticoagulation decisions during pregnancy
- What emerging research is changing how thrombotic risk in pregnancy is understood
Meet the speakers:
- Andres Rechner, Ph.D., presenter, diagnostic perspective
Andres Rechner, Ph.D., specializes in laboratory diagnostics and thrombotic risk assessment. He will present on how lab testing helps identify and monitor thrombotic risk before, during and after pregnancy. - Jim Douketis, M.D., treatment perspective
Jim Douketis, M.D., chairs the World Thrombosis Day campaign and is an expert in thrombosis treatment and anticoagulation management. He will discuss how lab support informs treatment decisions for thrombotic risk in pregnancy. - Prof. Beverley Hunt, O.B.E. – research perspective
Prof. Beverley Hunt, O.B.E. is a professor of thrombosis and haemostasis at King’s College London and a founding member of the World Thrombosis Day steering committee. She will discuss how clinical evidence shapes the diagnosis and management of thrombotic risk throughout pregnancy.
Thank you to Sysmex Europe for the support of the World Thrombosis Day campaign and this webinar.
